8281 — Xebio Holdings Co Balance Sheet
0.000.00%
- ¥44bn
- ¥36bn
- ¥251bn
- 62
- 84
- 41
- 72
Annual balance sheet for Xebio Holdings Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 44,323 | 39,893 | 32,890 | 24,941 | 19,855 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 23,294 | 23,153 | 24,011 | 23,233 | 20,716 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 146,628 | 147,012 | 145,805 | 139,969 | 130,727 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31,899 | 31,891 | 35,385 | 36,539 | 39,310 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 207,482 | 208,308 | 211,300 | 209,530 | 203,959 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 69,793 | 74,684 | 72,177 | 70,559 | 66,568 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 91,166 | 89,642 | 88,935 | 85,078 | 82,239 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 116,316 | 118,666 | 122,365 | 124,452 | 121,720 |
| Total Liabilities & Shareholders' Equity | 207,482 | 208,308 | 211,300 | 209,530 | 203,959 |
| Total Common Shares Outstanding |